Clik here to view.
Shiseido’s Social Business Model in Bangladesh Recognized as Initiative of...
TOKYO Shiseido’s activity in Bangladesh to improve social status and lifestyle of rural women by skincare products was recognized as “Business Call to Action*1 (hereinafter, “BCtA”)” led by the...
View ArticleClik here to view.
摩根大通携员工为缓解欧洲难民危机捐款最多200万美元
纽约 (美国商业资讯)–摩根大通公司今日宣布，为了向难民提供迅速援助并帮助缓解欧洲难民危机，其基金会将携公司员工提供最多200万美元的捐款。摩根大通基金会将拨款100万美元用于支持拯救儿童基金会(Save the Children)、国际乐施会(Oxfam)、国际救援委员会(International Rescue Committee)与国际医疗队(International Medical...
View ArticleClik here to view.
ファインデックス、企業・医療機関の両方で利用可能なストレスチェックシステムを販売開始
愛媛県松山市 （ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649 本社：愛媛県松山市三番町4-9-6 社長：相原輝夫）は、2015年9月16日より「DocuMaker ストレスチェックシステム」を販売いたします。...
View ArticleClik here to view.
Clik here to view.
Mitobridge Announces Sponsored Research Agreement to Evaluate PPARδ Compounds...
CAMBRIDGE, Mass. Mitobridge, Inc., a biopharmaceutical company pioneering the discovery and development of products that improve mitochondrial function, announces the signing of a sponsored research...
View ArticleClik here to view.
Cigna Foundation Renews World of Difference Grant to Samahope
BLOOMFIELD, Conn. The Cigna Foundation today announced it will renew its World of Difference grant for $150,000 to Samahope, a non-profit that funds treatments for those who otherwise would not have...
View ArticleClik here to view.
Physio-Control收购HeartSine®
华盛顿州雷德蒙德 (美国商业资讯)–Physio-Control与总部在北爱尔兰的自动体外除颤仪(AED)制造商HeartSine Technologies今天宣布，已就前者收购后者达成协议。这两家私有公司近期完成了尽职调查。此次交易的财务细节并未披露。此次合并使之成为世界上最大的AED解决方案提供商之一。 Smart News...
View ArticleClik here to view.
Ativa Medical Secures $15 Million in Series B Funding
ST. PAUL, Minn. Ativa Medical, developer of the world’s first diagnostic micro lab designed to assist physicians by enabling faster treatment decisions, today announced that it raised $15 million in...
View ArticleClik here to view.
Cell Signaling Technology宣布发布首款上市的IHC核准的VISTA抗体
纽约 (美国商业资讯)–全球性抗体提供商Cell Signaling Technology, Inc. (CST)今天宣布发布用于生物医学研究的首款上市的IHC核准的人类特异性VISTA兔单克隆抗体(mAb)。该消息是在CRI-CIMT-EATI-AACR 首届国际癌症免疫疗法会议上宣布的，此次会议于2015年9月16-19日在纽约州纽约市召开，主题是将科学转化为生存。 VISTA（...
View ArticleClik here to view.
フィジオコントロールがハートサインを買収へ
米ワシントン州レドモンド （ビジネスワイヤ） — フィジオコントロールが北アイルランドに拠点を置く自動体外式除細動器（AED）メーカーのハートサイン・テクノロジーズを買収する契約を締結したと、両社は本日発表しました。非公開企業である両社はデューデリジェンスを最近完了しました。取引の財務面の詳細は開示されていません。合併により世界最大級のAEDソリューションプロバイダーが誕生します。...
View ArticleClik here to view.
NCKU Raises Awareness on Dengue Prevention among International Students
TAINAN, Taiwan The staff members at National Cheng Kung University (NCKU), Tainan, Taiwan, took a real interest in making sure the international students were taken good care of when Tainan battles...
View ArticleClik here to view.
NovoCure Limited Announces Launch of Initial Public Offering
ST. HELIER, Jersey NovoCure Limited, a commercial stage oncology company pioneering a novel therapy for solid tumors, announced today the launch of its initial public offering of 12,500,000 shares...
View ArticleClik here to view.
Clik here to view.
Takeda to Highlight Ixazomib Clinical Development Program at Upcoming...
ROME Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it will highlight the ixazomib clinical development program during multiple poster sessions at the upcoming 15th...
View ArticleClik here to view.
GE Healthcare Announces $300 Million Commitment to Support Emerging Market...
NEW YORK GE Healthcare, the $18 billion healthcare technology division of GE (NYSE: GE), today announced the creation of a new business unit, Sustainable Healthcare Solutions (SHS), that will...
View ArticleClik here to view.
Opening of Mars, Incorporated Global Food Safety Center Signals Invitation...
MCLEAN, Va. & HUAIROU, China Mars, Incorporated announced today the opening of its Global Food Safety Center, a first-of-its-kind facility for pre-competitive research and training that aims to...
View ArticleClik here to view.
Clik here to view.
武田在即将召开的国际骨髓瘤研讨会上介绍Ixazomib临床开发项目
罗马 (美国商业资讯)–武田药品工业株式会社(TSE: 4502)今天宣布，将在第15届国际骨髓瘤研讨会(IMW 2015)的多个壁报分会场上介绍ixazomib 临床开发项目，此次研讨会将于2015年9月23至26日在意大利罗马召开。 武田肿瘤治疗领域部门副总裁Dixie-Lee Esseltine, MD,...
View ArticleClik here to view.
武田薬品が来る国際骨髄腫ワークショップでイキサゾミブの臨床開発プログラムについて報告
ローマ （ビジネスワイヤ）– 武田薬品工業株式会社（TSE: 4502）は本日、2015年9月23～26日にイタリアのローマで開催される第15回国際骨髄腫ワークショップ（IMW 2015）の複数のポスターセッションで、イキサゾミブの臨床開発プログラムについて報告すると発表しました。 武田薬品Oncology Therapeutic Area...
View ArticleClik here to view.
KineMed Announces License Agreement to Develop Late-Stage Synthetic Ghrelin
EMERYVILLE, Calif. & TOKYO KineMed, Inc. announced today that it has entered into an agreement with BioPharma Forest, Inc. to develop and commercialize synthetic Ghrelin. Under the terms of the...
View Article